• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

SimonMed Imaging Adopts cmAngio for Early Breast Cancer Detection

by Jasmine Pennic 11/05/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– CureMetrix, an innovator in AI-driven mammography solutions, has partnered with SimonMed Imaging, a prominent provider of outpatient medical imaging services in the United States. 

– The strategic collaboration will bring CureMetrix’s cutting-edge AI technology, cmAngio, to SimonMed Imaging’s extensive network of facilities across the nation.

cmAngio: Enhancing Breast Cancer Detection with AI

cmAngio is an FDA-cleared AI-powered software designed to analyze mammograms and detect potential indicators of breast cancer, including Breast Arterial Calcifications (BAC). The software seamlessly integrates with existing mammography systems, providing radiologists with an additional layer of analysis to aid in the early detection and diagnosis of breast cancer.

Key Features and benefits of cmAngio include:

  • AI-Powered Accuracy: cmAngio leverages advanced AI algorithms to identify and localize BAC with exceptional precision.
  • Seamless Integration: The software seamlessly integrates with both full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) systems, making it easily adaptable to various clinical settings.
  • Enhanced Efficiency: cmAngio streamlines the mammography analysis process, assisting radiologists in efficiently identifying potential areas of concern.
  • Improved Patient Outcomes: By aiding in the early detection of breast cancer, cmAngio contributes to improved patient outcomes and survival rates.

“At SimonMed Imaging, our motto ‘See Tomorrow Today’ reflects our belief that new technology can help provide more accurate diagnoses, but it must also be readily available and affordable to make a real impact,” said Dr. John Simon, Chief Executive Officer at SimonMed Imaging. “Our partnership with CureMetrix and the integration of cmAngio is a testament to this mission. By combining innovative tools with the expertise of our subspecialty-trained radiologists, we continue to deliver the highest quality care in a cost-effective and service-oriented environment, empowering better health outcomes for our patients.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |